(Q34168958)

English

An overview of gamma-hydroxybutyric acid: pharmacodynamics, pharmacokinetics, toxic effects, addiction, analytical methods, and interpretation of results

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

An overview of gamma-hydroxybutyric acid: pharmacodynamics, pharmacokinetics, toxic effects, addiction, analytical methods, and interpretation of results (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

H Andresen

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

B E Aydin

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

A Mueller

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

S Iwersen-Bergmann

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

4 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Drug Testing and Analysis

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

560-568

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Determination of gamma-hydroxybutyrate (GHB) in biological specimens by gas chromatography--mass spectrometry.

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

From Club Drug to Orphan Drug: Sodium Oxybate (Xyrem) for the Treatment of Cataplexy

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Prevalence of drugs used in cases of alleged sexual assault

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Analysis of GHB and 4-methyl-GHB in postmortem matrices after long-term storage

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Application of a convenient extraction procedure to analyze gamma-hydroxybutyric acid in fatalities involving gamma-hydroxybutyric acid, gamma-butyrolactone, and 1,4-butanediol

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Gamma-butyrolactone and 1,4-butanediol: abused analogues of gamma-hydroxybutyrate

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

GHB: a new and novel drug of abuse

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Distribution of GHB in tissues and fluids following a fatal overdose

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

The gamma-hydroxybutyrate signalling system in brain: organization and functional implications.

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Gamma-hydroxybutyrate--a drug of abuse

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Evidence for a G protein-coupled gamma-hydroxybutyric acid receptor

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

A sudden awakening from a near coma after combined intake of gamma-hydroxybutyric acid (GHB) and ethanol.

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Abrupt awakening phenomenon associated with gamma-hydroxybutyrate use: a case series.

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Gamma-hydroxybutyrate serum levels and clinical syndrome after severe overdose

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Intoxication due to 1,4-butanediol

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Intoxications due to ingestion of gamma-butyrolactone: organ distribution of gamma-hydroxybutyric acid and gamma-butyrolactone

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Clinical pharmacology of 1,4-butanediol and gamma-hydroxybutyrate after oral 1,4-butanediol administration to healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

The influence of gender and food on the pharmacokinetics of sodium oxybate oral solution in healthy subjects

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Effect of moderate or severe liver dysfunction on the pharmacokinetics of gamma-hydroxybutyric acid.

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Relationship between pharmacological effects and blood and brain levels of gamma-butyrolactone and gamma-hydroxybutyrate

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Characterization of the Pharmacokinetic and Pharmacodynamic Interaction between Gamma-Hydroxybutyrate and Ethanol in the Rat

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Evidence for the participation of a cytosolic NADP+-dependent oxidoreductase in the catabolism of gamma-hydroxybutyrate in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Concentration-time profiles of gamma-hydroxybutyrate in blood after recreational doses are best described by zero-order rather than first-order kinetics

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Toxicological findings in cases of alleged drug-facilitated sexual assault in the United Kingdom over a 3-year period

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Driving under the influence of gamma-hydroxybutyrate (GHB).

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Forensic cases involving the use of GHB in The Netherlands

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Addicted to driving under the influence--a GHB/GBL case report

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Unusually high concentrations in a fatal GHB case

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Forensic toxicology findings in deaths involving gamma-hydroxybutyrate

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Gamma-hydroxybutyrate withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Gamma-hydroxybutyrate withdrawal syndrome: dangerous but not well-known

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

In vitro production of gamma-hydroxybutyrate in antemortem urine samples

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Further evidence of in vitro production of gamma-hydroxybutyrate (GHB) in urine samples

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Elevated GHB in citrate-buffered blood.

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Ultra-rapid procedure to test for gamma-hydroxybutyric acid in blood and urine by gas chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Gamma hydroxybutyric acid (GHB) concentrations in humans and factors affecting endogenous production

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

The urinary excretion of gamma-hydroxybutyric acid in man.

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Analysis of gamma-hydroxybutyrate (GHB) in urine by gas chromatography-mass spectrometry.

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Analysis of biofluids for gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL) by headspace GC-FID and GC-MS.

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Therapeutic gamma-hydroxybutyric acid monitoring in plasma and urine by gas chromatography-mass spectrometry.

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Determination of gamma-hydroxybutyric acid in clinical samples using capillary electrophoresis with contactless conductivity detection

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Determination of gamma-hydroxybutyric acid in biological fluids by using capillary electrophoresis with indirect detection.

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Rapid and direct analysis of gamma-hydroxybutyric acid in urine by capillary electrophoresis-electrospray ionization ion-trap mass spectrometry.

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Gamma-hydroxybutyrate: bridging the clinical-analytical gap.

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Determination of endogenous gamma-hydroxybutyric acid (GHB) levels in antemortem urine and blood

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

What constitutes a normal ante-mortem urine GHB concentration?

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Gamma-hydroxybutyrate in urine and serum: additional data supporting current cut-off recommendations

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Carbon isotopic ratio analysis by gas chromatography/combustion/isotope ratio mass spectrometry for the detection of gamma-hydroxybutyric acid (GHB) administration to humans.

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Site-dependent production of gamma-hydroxybutyric acid in the early postmortem period

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Twenty-three deaths with gamma-hydroxybutyrate overdose in western Sweden between 2000 and 2007.

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

GHB in postmortem toxicology. Discrimination between endogenous production from exposure using multiple specimens

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Further evidence for the presence of GHB in postmortem biological fluid: implications for the interpretation of findings

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

The presence of gamma-hydroxybutyric acid (GHB) in postmortem biological fluids

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Endogenous gamma-hydroxybutyric acid levels in postmortem blood

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

21 January 2018

Withdrawal from gamma-hydroxybutyrate, 1,4-butanediol and gamma-butyrolactone: a case report and systematic review.

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel method for GHB detection in urine and its application in drug-facilitated sexual assaults

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of GHB in urine and serum by LC/MS using a simple one-step derivative

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

7 January 2021

based on heuristic

inferred from DOI database lookup

Gamma-hydroxybutyric acid stability and formation in blood and urine

1 reference

https://api.crossref.org/works/10.1002%2FDTA.254

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DTA.254

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34168958&oldid=2143943359"